Global burden of cancer in women, 1990–2021: a systematic analysis from the GBD 2021 study
The global burden of female cancers presents a significant public health challenge. Disparities in female cancer burden reflect inequities in healthcare access and rising metabolic risks. Priority actions include HPV vaccination, low-cost screening, and obesity control. Equity-focused, data-informed policies are crucial to reduce global disparities.
Authors
- Shijie Zhu (ORCID: https://orcid.org/0000-0003-1931-7430)
- Bin Hu (ORCID: https://orcid.org/0000-0002-3152-1402)
- Yebo Gao (ORCID: https://orcid.org/0000-0001-9555-4724)
- Ling Fu (ORCID: https://orcid.org/0000-0003-2513-1405)
- Yuting He (ORCID: https://orcid.org/0000-0001-7133-9501)
- Zhixun Ding (ORCID: https://orcid.org/0000-0002-0977-9976)
- Zhe Wan (ORCID: https://orcid.org/0000-0001-8088-1677)
- Shuyu Li (ORCID: https://orcid.org/0000-0002-7586-0430)
- Chao Luo (ORCID: https://orcid.org/0000-0002-7127-3861)
- Yun Mao
- Wen Cao (ORCID: https://orcid.org/0000-0003-2883-8553)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Wangjing Hospital of China Academy of Chinese Medical Sciences (CN)
- Yueyang Hospital (CN)
- Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine (CN)
- Anyang Hospital of Traditional Chinese Medicine (CN)
- China Agricultural University (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-08-11
- DOI
- https://doi.org/10.3389/fonc.2025.1633894
- Citations
- 7
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 7.32
Funders
- National Natural Science Foundation of China
- Hunan University
- Hunan University of Chinese Medicine